length polymorphism (LL). The two remaining pedigrees studied had diabetic members doubly heterozygous for fragment length polymorphisms, and our results showed no linkage between maturity onset diabetes of the young and the variable region polymorphism. In family 1 the diabetic patients did not share any of the three different short polymorphisms foundthat is, La', Lb, or LC. In family 2 all three diabetic members shared a short polymorphism (L). The propositus (subject IV 2), however, had clearly inherited his diabetes and the long polymorphism (U) from his mother and the short polymorphism (L) from his non-diabetic father (fig 3) . Thus the diabetes was evidently not linked to the short polymorphism (L) .
These pedigrees show the usefulness of the insulin fragment length polymorphism as a genetic marker. In the two families studied maturity onset diabetes of the young was clearly not linked to a defect in or around the insulin gene. The discovery of the chromosomal location of the presumed abnormal gene present in this type of diabetes must await the application of new genetic markers.
We thank G Bell for the gift of the insulin probe pH Ins 214. Correspondence to JSW.
"Rotwein P, Chyn R, Chirgwin J, Cordell To determine whether the binding of human thyroid stimulating hormone by maternal IgG might interfere with the biological activity of the hormone the effect of the maternal polyethylene glycol precipitate was studied in a bioassay system for human thyroid stimulating hormone." This assay measures the ability of thyroid stimulating hormone to stimulate iodine organification by cultured porcine thyroid follicular cells. At the end of the incubation the cells were dissolved in 1 mol sodium hydroxide and 125I organification was assessed by counting the pellets obtained by trichloracetic acid precipitation.
Results
The concentration of thyroid stimulating hormone on the filter paper blood sample obtained from the baby seven days after birth was 104 mU/l. Repeat testing on the same filter paper spot and on a fresh filter paper spot gave similar results. Serum concentrations were: thyroxine 180 nmol/l (14-0 ,ug/100 ml), free thyroxine 22 pmol/l (1-7 ng/100 ml), triiodothyronine 3-1 nmol/l (202 ng/100 ml), and thyroxine binding globulin 25-5 mg/l. These results were all normal. Serum bilirubin concentration was normal. Other serum hormone concentrations were prolactin 1520 mU/l, luteinising hormone 2-8 U/l, follicle stimulating hormone 4-7 U/1, and i-human chorionic gonadotrophin < 2-5 IU/l (normal less than 5 IU/1). No thyroid antibodies were detected in the baby's serum. A thyroid scan using 123I confirmed the presence of a functioning gland in the normal position.
593
Maternal thyroid function tests 10 days post partum showed the following concentrations: serum thyroxine 80 nmol/l (6-2 tkg/100 ml) (normal ranges 55-150 nmol/l (4-3-11-7 ug/100 ml)), free thyroxine 14 pmol/l (1 1 ng/100 ml) (normal range 9-22 pmol/l (0-7-1-7 ng/100 ml)), triiodothyronine 1-6 nmol/l (104 ng/100 ml) (normal range 1-5-3-5 nmol/l (98-228 ng/100 ml)), and thyroxine binding globulin 28 5 mg/l (normal range 12-31 mg/l). No circulating thyroid antibodies were found. The raised concentration of thyroid stimulating hormone rose by 25% 20 minutes after thyrotrophin releasing hormone (200 ,ug) was given intravenously, from 33-1 to 41-1 mU/l (immunoradiometric assay). Serum triiodothyronine concentration rose from 1-6 nmol/l (104 ng/100 ml) to 1-8 nmol/l (117 ng/100 ml) two hours after thyrotrophin releasing hormone was given, indicating release of biologically active thyroid stimulating hormone. Serum prolactin concentration was 3649 mU/l (while breast feeding; normal <420 mU/l), luteinising hormone 3-9 U/1, follicle stimulating hormone 4-4 U/1, and 5-human chorionic gonadotrophin 1 IU/l (normal <5 IU/1). Urea and electrolyte concentrations, results of routine liver function tests, and serum IgG, IgA, and IgM concentrations were all normal. Results of a screening test for rheumatoid arthritis were negative.
A venous blood sample taken 13 days post partum showed a concentration of thyroid stimulating hormone in undiluted baby serum to be 48 mU/l and in serum diluted one in four 123 mU/l. Dilutions of maternal and baby sera in serum that was free of thyroid stimulating hormone produced curves in both assays that were not parallel to the MRC 68/38 thyroid stimulating hormone standard (figure). adding large amounts of "cold" thyroid stimulating hormone (table) . The maternal IgG precipitate also inhibited the action of human thyroid stimulating hormone in the bioassay system. The maternal concentration of thyroid stimulating hormone measured seven months post partum was 28 mU/l, while the concentration in the baby at that time had fallen to within the normal range (< 5 mU/l). No significant binding of maternal IgG precipitate or purified maternal IgG to bovine thyroid stimulating hormone was observed. In the bioassay there was no significant difference in organification between control and maternal samples when no thyroid stimulating hormone was added. *10 g/l. t5 g/l.
+Organification control expressed as 100"',.
Discussion
This baby had a high concentration of thyroid stimulating hormone as measured by the conventional assay used in screening for neonatal hypothyroidism and confirmed on examination of the serum with two independent radioimmunoassays. The high concentration of the hormone in the maternal serum and the subsequent biochemical investigations on both sera suggested that the concentrations in the baby and mother were falsely raised. In addition the baby had normal serum concentrations of thyroid hormones and the gland was in the normal position on scanning.
Thyroid function was normal in the mother, who appeared to have a normal response of thyroid stimulating hormone to thyroid releasing hormone, though this test is difficult to evaluate because of the high background value.
Falsely raised serum concentrations of thyroid stimulating hormone have been described in adults, and Hendenborg et all2 found that in 5%' of all sera with high concentrations these were due to the presence of heterophilic antibodies against rabbit IgG. The high concentrations were abolished if small amounts of rabbit IgG were added to the serum before assay. There are reports of false hyperthyrotrophinaemia due to the presence of heterophilic antibodies to thyroid stimulating hormone in paired maternal and neonatal sera obtained in screening programmes."" Some of these antibodies bind to the hormone in addition to acting as heterophilic antibodies. '5 In one study all mothers had received injections of a microbial vaccine containing rabbit serum, and possibly the antibodies were transferred to the fetus during pregnancy.
We believe that the material from the mother had no hetero- '7 but this is a rare phenomenon and does not seem to be present in the sera of patients with pituitary tumours. We have no indication of why this maternal antibody appeared in the circulation, especially as the mother was entirely well and had no history of immune disorder. The incidence of transient hyperthyrotrophinaemia is not known, but two studies have shown incidences of between roughly one in 1000 and one in 10 000 live births. One case was described in which the maternal concentration of thyroid stimulating hormone was normal,"8 but in others4 maternal sera were not examined.
This case has important implications for neonatal hypothyroid screening programmes that use measurement of concentrations of thyroid stimulating hormone as the initial test. The incidence of this condition is not known, and it is important to avoid inappropriate replacement treatment. Clearly, any infant found to have a high concentration of thyroid stimulating hormone but in whom the serum thyroxine concentration is within normal limits and who has a demonstrable thyroid gland in the normal position must be evaluated for a false positive result. Maternal concentrations of thyroid stimulating hormone and thyroid function should be checked and, if laboratory facilities permit, appropriate tests done to determine the cause of the raised hormone concentration.
